Endometriosis & GNRHas Hormone Suppressants for Pain: "There was also a greater decrease of Bone Mineral Density (BMD) when women were treated with GnRHas alone, compared to GnRHas in conjunction with calcium‐regulating agents. Thus, there may be an in
RT @CochraneCGF: Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associa…
Analogues de l'hormone de libération de la gonadotrophine pour l'endométriose ➡️Revue @CochraneCGF évaluant 72 essais impliquant 7355 femmes 💻Résumé disponible sur @CochraneLibrary 🔗https://t.co/6la4OehG70
RT @CochraneCGF: Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associa…
RT @CochraneLibrary: What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associated with #endomet…
RT @CochraneLibrary: What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associated with #endomet…
What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associated with #endometriosis? 📚 72 trials that involved 7355 with endometriosis included in this @CochraneCGF #SystematicReview https://t.co/dnTKTuj2kw
RT @alfonso_casi: Análogos de la hormona liberadora de gonadotropina para la endometriosis: Para el alivio del dolo, podría haber una liger…
Análogos de la hormona liberadora de gonadotropina para la endometriosis: Para el alivio del dolo, podría haber una ligera disminución a favor del tratamiento con análogos de la GnRH en comparación con placebo o progestágenos orales o inyectables... https:
RT @CochraneCGF: Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associa…
RT @CochraneCGF: Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associa…
RT @CochraneLibrary: JUST PUBLISHED - What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associa…
RT @CochraneLibrary: JUST PUBLISHED - What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associa…
Endométriose: 6 à 11 % des femmes en âge de procréer Traitement par analogues de GnRH #RevSyst 72 ECR (7355 patientes), données probantes: qualité très faible / faible -> légère diminution de la douleur globale avec GnRH @CochraneLibrary @cochranecollab
RT @CochraneLibrary: JUST PUBLISHED - What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associa…
RT @CochraneLibrary: JUST PUBLISHED - What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associa…
JUST PUBLISHED - What are the benefits and risks of gonadotrophin‐releasing hormone analogues #GnRHas for pain associated with #endometriosis? 📚 72 trials that involved 7355 with endometriosis included in this @CochraneCGF #SystematicReview https://t.co/
GnRHas for endo - what is the current #evidence #endometriosis #research #hormones #pain
RT @CochraneCGF: Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associa…
RT @CochraneCGF: Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associa…
Hot off the press! What are the benefits and risks of gonadotrophin‐releasing hormone analogues (GnRHas) for #pain associated with #endometriosis? @cochranecollab @CochraneLibrary https://t.co/PmzRHXNfTZ https://t.co/Z86V36EsPQ